RIVAROXABAN SAFETY DURING DEEP VEIN THROMBOSIS TREATMENT IN PATIIENTS WITH RELATED DAMAGES OF STOMACH AND DUODENUM
The aim of this study was to assess the risk of use of rivaroxaban, which was associated with gastro-duodenal bleeding in patients with deep venous thrombosis. Methods: an analysis of anticoagulant treatment in 683 patients with deep venous phlebothrombosis. All the patients underwent fiberoptic gas...
Main Authors: | E. A. Shcheglov, N. N. Alontseva, P. S. Guliaeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«REMEDIUM GROUP» Ltd.
2019-06-01
|
Series: | Атеротромбоз |
Subjects: | |
Online Access: | https://www.aterotromboz.ru/jour/article/view/181 |
Similar Items
-
СОВРЕМЕННЫЙ ПОДХОД В ЛЕЧЕНИИ ОСТРОГО ТРОМБОЗА ГЛУБОКИХ ВЕН ПРЕПАРАТОМ РИВАРОКСАБАН
by: Е. П. Кривощеко в, et al.
Published: (2015-06-01) -
CONSIDERING QUESTION OF SAFETY OF DIRECT ORAL ANTICOAGULANTS: THE RESULTS OF THE COMPARISON OF APIXABAN AND WARFARIN
by: Igor S. Yavelov
Published: (2018-12-01) -
RISK FACTORS OF EROSIVE ULCER LESION OF STOMACH AND DUODENUM IN THOSE SUFFERING FROM SEVERE THERMAL INJURY
by: D. O. Vagner, et al.
Published: (2018-01-01) -
Modern approaches in the treatment of patients with Paget-Schretter syndrome
by: I. N. Sonkin, et al.
Published: (2021-11-01) -
Clinical case of a paradoxical embolism that caused an acute myocardial infarction after deep vein thrombosis
by: Yu. V. Larchikova, et al.
Published: (2020-12-01)